Financial News

Financial Report: Sanofi

Pharmaceutical sales up 3% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi 1Q Revenues: €8.4 billion  (+6%) 1Q Earnings: €1.8 billion (+11%) Comments: Pharmaceutical sales were €6.3 billion in the quarter, up 3%. Genzyme sales were up 31% to €2.0 billion, driven by Dupixent, with sales of €329 million, and consolidation of Bioverativ. Vaccines sales were up 21% to €873 million, reflecting growth of Pentaxim in China and Menactra in Emerging Markets. Primary Care sales were down 17% to €2.3 billion  impacted by lower diabetes sales and divestiture of EU generi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters